Form 4 for CTAS Cintas
Accepted 2024-08-02 00:00:00 ET · period of report 2024-07-31 · accession 0000892251-24-000079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-02 | 2024-07-31 | CTAS | Rozakis Jim | EVP, COO | F - Tax | $765.54 | -8,047 | 59.1K | -12% | -$6.16M |
| DM | 2024-08-02 | 2024-07-31 | CTAS | Rozakis Jim | EVP, COO | M - OptEx | $309.35 | +12.1K | 62.3K | +24% | +$3.74M |
| DM | 2024-08-02 | 2024-07-31 | CTAS | Rozakis Jim | EVP, COO | M - OptEx | $0.00 | -12.1K | 8,450 | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | F | D | 2,558 | $765.38 | 60,574 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-31 | F | D | 1,354 | $765.68 | 61,943 | D | — | — | |
| 3 | Common | Common Stock | 2024-07-31 | M | A | 2,068 | $293.56 | 63,297 | D | — | — | |
| 4 | Common | Common Stock | 2024-07-31 | F | D | 1,075 | $765.38 | 61,229 | D | — | — | |
| 5 | Common | Common Stock | 2024-07-31 | M | A | 4,224 | $388.86 | 62,136 | D | — | — | |
| 6 | Common | Common Stock | 2024-07-31 | F | D | 3,060 | $765.68 | 59,076 | D | — | — | |
| 7 | Common | Common Stock | 2024-07-31 | M | A | 4,056 | $260.79 | 63,132 | D | — | — | |
| 8 | Common | Common Stock | 2024-07-31 | M | A | 1,730 | $247.96 | 62,304 | D | — | — | |
| 9 | Derivative | Stock Option (right to buy) | 2024-07-31 | M | D | 4,056 | $0.00 | 0 | D | $260.79 · — to 2029-07-23 | 4,056 Common Stock | (F1) The options are exercisable in three annual installments on the third, fourth, and fifth anniversary of the grant date. |
| 10 | Derivative | Stock Option (right to buy) | 2024-07-31 | M | D | 2,068 | $0.00 | 2,068 | D | $293.56 · — to 2030-07-26 | 2,068 Common Stock | (F1) The options are exercisable in three annual installments on the third, fourth, and fifth anniversary of the grant date. |
| 11 | Derivative | Stock Option (right to buy) | 2024-07-31 | M | D | 1,730 | $0.00 | 1,730 | D | $247.96 · — to 2030-05-29 | 1,730 Common Stock | (F1) The options are exercisable in three annual installments on the third, fourth, and fifth anniversary of the grant date. |
| 12 | Derivative | Stock Option (right to buy) | 2024-07-31 | M | D | 4,224 | $0.00 | 8,450 | D | $388.86 · — to 2031-07-27 | 4,224 Common Stock | (F1) The options are exercisable in three annual installments on the third, fourth, and fifth anniversary of the grant date. |